CareLit Fachartikel

Sensitivity of primary Glioblastoma cell lines towards Cilengitide alone and in combination with Temozolomide

J Schubert, C Mullins, J Piek, CF Classen · Klinische Pädiatrie · 2012 · Heft 11

Dokument
926118
CareLit-ID
Jahr
2012
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Pädiatrie
Autor:innen
J Schubert, C Mullins, J Piek, CF Classen
Ausgabe
Heft 11 / 2012
Seiten
–
Erschienen: 2012-11-09 00:00:00
ISSN
0300-8630

Zusammenfassung

Glioblastoma multiforma (GBM) still has a very poor prognosis even with today's aggressive combination therapy of resection followed by radio-chemotherapy with Temozolomide. It is mainly characterized by an enormous high level of tumor vascularization and infiltrative growth.In both these processes, integrins play an important role as transmembrane heterodimeric glycoproteins mediating the interaction between cells and the extracellular matrix. Especially the subtypes αvβ3 and αvβ5 are currently identified to be expressed on both tumorinvasive endothelia and Glioblastoma cells. Recent clinical data support a pos…

Schlagworte

Klinische Pädiatrie